IE 11 is a very old Browser and it`s not supported on this site
de en
Interim report as at 31.03.2025
de en
Business reportPerformance / Multi-year comparison

Performance/Multi-year comparison

Indexed performance since launch

BB Biotech AG (SIX)-CHF


Rolling performance

SHARE

NAV

NBI TR

31.03.2024 – 31.03.2025

(29.1%)

(17.4%)

(5.2%)

31.03.2023 – 31.03.2024

(4.8%)

13.5%

6.8%

31.03.2022 – 31.03.2023

(18.4%)

(11.2%)

(1.1%)

31.03.2021 – 31.03.2022

(16.7%)

(23.6%)

(13.0%)

31.03.2020 – 31.03.2021

63.3%

67.9%

36.7%

Annual performance

SHARE

NAV

NBI TR

2024

(13.5%)

3.0%

7.6%

2023

(18.1%)

(7.4%)

(4.8%)

2022

(24.3%)

(11.0%)

(9.1%)

2021

8.3%

(11.5%)

3.0%

2020

19.3%

24.3%

15.8%

Cumulated performance

31.03.2025

SHARE

NAV

NBI TR

YTD

(8.8%)

(10.8%)

(3.9%)

1 year

(29.1%)

(17.4%)

(5.2%)

3 years

(44.9%)

(16.8%)

0.2%

5 years

(25.1%)

6.8%

19.0%

10 years

(14.5%)

(5.9%)

14.1%

since inception 1)

1 462%

1 700%

1 240%

1 09.11.1993

Annualized performance

31.03.2025

SHARE

NAV

NBI TR

1 year

(29.1%)

(17.4%)

(5.2%)

3 years

(18.0%)

(5.9%)

0.1%

5 years

(5.6%)

1.3%

3.5%

10 years

(1.6%)

(0.6%)

1.3%

since inception 1)

9.1%

9.6%

8.6%

1 09.11.1993

BB BIOTECH AG (XETRA)-EUR


Rolling performance

SHARE

NAV

NBI TR

31.03.2024 – 31.03.2025

(28.4%)

(16.1%)

(3.5%)

31.03.2023 – 31.03.2024

(2.1%)

15.8%

9.0%

31.03.2022 – 31.03.2023

(17.4%)

(8.6%)

1.8%

31.03.2021 – 31.03.2022

(9.4%)

(17.2%)

(5.8%)

31.03.2020 – 31.03.2021

58.5%

60.7%

30.8%

Annual performance

SHARE

NAV

NBI TR

2024

(14.1%)

1.7%

6.3%

2023

(15.2%)

(1.3%)

1.3%

2022

(19.0%)

(6.7%)

(4.5%)

2021

13.3%

(7.8%)

7.4%

2020

18.1%

24.8%

16.1%

Cumulated performance

31.03.2025

SHARE

NAV

NBI TR

YTD

(10.3%)

(12.3%)

(5.5%)

1 year

(28.4%)

(16.1%)

(3.5%)

3 years

(42.1%)

(11.2%)

7.0%

5 years

(16.8%)

18.2%

31.9%

10 years

(7.0%)

2.7%

24.6%

since inception 1)

1 306%

1 533%

1 373%

1 10.12.1997

Annualized performance

31.03.2025

SHARE

NAV

NBI TR

1 year

(28.4%)

(16.1%)

(3.5%)

3 years

(16.6%)

(3.9%)

2.3%

5 years

(3.6%)

3.4%

5.7%

10 years

(0.7%)

0.3%

2.2%

since inception 1)

10.2%

10.8%

10.3%

1 10.12.1997

Multi-year comparison

31.03.2025

2024

2023

2022

2021

Market capitalization at the end of the period (in CHF mn)

1 692.5

1 961.2

2 368.4

3 058.1

4 274.1

highchart-toggle

Net Asset Value at the end of the period (in CHF mn)

1 944.5

2 286.3

2 323.2

2 686.1

3 283.5

highchart-toggle

Number of shares (in mn)

55.4

55.4

55.4

55.4

55.4

highchart-toggle

Trading volume (in CHF mn)

280.7

974.0

906.3

1 482.0

2 101.0

highchart-toggle

Profit/(loss) (in CHF mn)

(240.9)

75.9

(206.6)

(357.8)

(404.8)

highchart-toggle

Closing price at the end of the period in CHF

30.55

35.40

42.75

55.20

77.15

highchart-toggle

Closing price at the end of the period in EUR

31.80

37.45

45.50

56.70

74.05

highchart-toggle

Stock performance (incl. distributions) 1)

(8.8%)

(13.5%)

(18.1%)

(24.3%)

8.3%

highchart-toggle

High/low share price in CHF

40.65/30.55

49.35/35.30

60.70/35.60

78.15/51.00

92.20/73.40

highchart-toggle

High/low share price in EUR

43.00/31.80

52.00/37.45

60.50/37.10

75.40/49.60

86.20/67.80

highchart-toggle

Premium/(discount) (annual average)

(12.4%)

(6.6%)

7.5%

20.5%

19.5%

highchart-toggle

Dividend in CHF

N.A.

1.80

2.00

2.85

3.85

highchart-toggle

Degree of investment (quarterly figures)

95.6%

111.3%

113.7%

112.8%

108.6%

highchart-toggle

Total Expense Ratio (TER) p.a. 2)

1.34%

1.33%

1.34%

1.27%

1.22%

highchart-toggle

1All figures in CHF %, total return-methodology

2Based on market capitalization